This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Steinhoff, M C Articles by Murphy, B R Search for Related Content PubMed PubMed Citation Articles by Steinhoff, M C Articles by Murphy, B R

Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.

Department of International Health, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205.

ABSTRACT

Resistance to infection with an influenza A virus conferred by previous infection with an influenza A virus belonging to another subtype is called heterosubtypic immunity. Heterosubtypic immunity is demonstrable in laboratory animals but is believed to be weak in humans. The present study examined whether heterosubtypic immunity from previous influenza virus infection induced resistance to infection with an attenuated influenza A vaccine virus. Two groups of vaccinees consisting of young infants and children who received either influenza A H1N1 or H3N2 attenuated virus were studied. Influenza A H3N2 virus vaccine recipients were classified by their preexisting H1N1 heterosubtypic antibody level induced by prior infection with wild-type virus, and the H1N1 vaccinees were classified by their history of infection with H3N2 vaccine virus. For both groups of vaccinees, the rates of seroconversion and virus shedding and the level of vaccine virus replication were compared in subjects with and without heterosubtypic immunity. In 48 influenza A H3N2 virus and 39 H1N1 virus vaccinees, heterosubtypic immunity had no demonstrable effect on infectivity, immunogenicity, or replication of attenuated vaccine virus. These observations confirm the weak nature of heterosubtypic immunity in humans and suggest that it will not limit the utility of live attenuated influenza A viruses in young infants and children.

This article has been cited by other articles:

• Rangel-Moreno, J., Carragher, D. M., Misra, R. S., Kusser, K., Hartson, L., Moquin, A., Lund, F. E., Randall, T. D. (2008). B Cells Promote Resistance to Heterosubtypic Strains of Influenza via Multiple Mechanisms. J. Immunol. 180: 454-463 [Abstract] [Full Text]  
• Powell, T. J., Strutt, T., Reome, J., Hollenbaugh, J. A., Roberts, A. D., Woodland, D. L., Swain, S. L., Dutton, R. W. (2007). Priming with Cold-Adapted Influenza A Does Not Prevent Infection but Elicits Long-Lived Protection against Supralethal Challenge with Heterosubtypic Virus. J. Immunol. 178: 1030-1038 [Abstract] [Full Text]  
• Steininger, C., Kundi, M., Aberle, S. W., Aberle, J. H., Popow-Kraupp, T. (2002). Effectiveness of Reverse Transcription-PCR, Virus Isolation, and Enzyme-Linked Immunosorbent Assay for Diagnosis of Influenza A Virus Infection in Different Age Groups. J. Clin. Microbiol. 40: 2051-2056 [Abstract] [Full Text]  
• Heinen, P. P., de Boer-Luijtze, E. A., Bianchi, A. T. J. (2001). Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection. J. Gen. Virol. 82: 2697-2707 [Abstract] [Full Text]  
• Tumpey, T. M., Renshaw, M., Clements, J. D., Katz, J. M. (2001). Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection. J. Virol. 75: 5141-5150 [Abstract] [Full Text]  
• Moskophidis, D., Kioussis, D. (1998). Contribution of  Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model. J. Exp. Med. 188: 223-232 [Abstract] [Full Text]